From the 42nd Annual Renaissance Ball in Philadelphia benefiting the Crohn's & Colitis Foundation, host Lu Ann Cahn talks with Dr. David Piccoli, Chief of the Division of Gastroenterology, Hepatology and Nutrition, Director of the Biesecker PediatricLiver Center, and a board-certified pediatric gastroenterologist at Children's Hospital of Philadelphia. Dr. Piccoli discusses the RISK study, supported by the Crohn’s & Colitis Foundation, and the challenges patients face with response to treatment. This pediatric study enrolled 1,800 patients at the time of their diagnosis and collected clinical, genetic, treatment and microbiome information to help to determine how the immune system works over time.
RISK Cohort Study in Crohn's Disease
RISK Cohort Study in Crohn's Disease
13
Lu Ann Cahn talks w/ Dr. Piccoli about the RISK study that enrolled 1,800 patients & collected a variety of info to learn more about the immune system
Publish Date
Release Date: 12/15/2017
Facebook Comments